Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Frontiers in Neurology|January 22, 2024
ATP13A2 (PARK9) and basal ganglia functionKristina M Croucher, Sheila M FlemingCurrent Environmental Health Reports|April 19, 2017
Mechanisms of Gene-Environment Interactions in Parkinson's DiseaseSheila M FlemingJournal of Parkinson'S Disease|August 13, 2013
Cardiovascular autonomic dysfunction in animal models of Parkinson's diseaseSheila M FlemingInternational Review of Neurobiology|November 11, 2009
Behavioral outcome measures for the assessment of sensorimotor function in animal models of movement disordersSheila M FlemingHandbook of Clinical Neurology|February 21, 2023
Role of rodent models in advancing precision medicine for Parkinson's diseaseEmily Simons, Sheila M FlemingBehavioural Pharmacology|August 31, 2006
Behavioral phenotypes and pharmacology in genetic mouse models of ParkinsonismSheila M Fleming, Marie-Françoise ChesseletBehavioural Brain Research|December 8, 2004
An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidateSheila M Fleming, Yvon Delville, Timothy SchallertNeuropharmacology|November 7, 2021
Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapiesSheila M Fleming, Ashley Davis, Emily SimonsJournal of Visualized Experiments : Jove|July 16, 2013
Assessment of sensorimotor function in mouse models of Parkinson's diseaseSheila M Fleming, Osunde R Ekhator, Valentins GhisaysILAR Journal|March 26, 2003
Experimental focal ischemic injury: behavior-brain interactions and issues of animal handling and housingTim Schallert, Martin T Woodlee, Sheila M FlemingPageof 5